Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 3,600.00
+15.00 (0.42%)
At close: Aug 28, 2025
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 279.91 billion as of August 28, 2025. Its market cap has decreased by -18.58% in one year.
Market Cap
279.91B
Enterprise Value
360.68B
Revenue
6.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,600.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 279.91B, a decrease of -54.36%. That is a compound annual growth rate of -16.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 279.91B | -28.97% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | 613.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 459.67T |
| SK hynix | 180.54T |
| LG Energy Solution | 89.15T |
| Samsung Biologics | 72.53T |
| Hyundai Motor Company | 47.74T |
| Hanwha Aerospace | 46.30T |
| HD Hyundai Heavy Industries | 41.55T |
| Doosan Enerbility | 40.54T |